Location · Columbus, OH
Clinical trials in Columbus, OH
322 recruiting studies have a site in the Columbus area, and 94 of them accept healthy volunteers. The area includes Dublin, Westerville, Hilliard, Gahanna, Grove City, Worthington and nearby cities.
322 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
AllRock Bio, Inc.
- Location
- Phoenix, AZ + 10 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
UCB Biopharma SRL
- Location
- Columbus, OH
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Eli Lilly and Company
- Location
- Mesa, AZ + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Eli Lilly and Company
- Location
- Mesa, AZ + 13 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Jazz Pharmaceuticals
- Location
- Birmingham, AL + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- Anniston, AL + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Eli Lilly and Company
- Location
- Birmingham, AL + 28 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
The HYALEX Pivotal Study
Hyalex Orthopaedics, Inc.
- Location
- La Mesa, CA + 3 other US sites
- Eligibility basics
- Ages 22–70
- RecruitingPhase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Eli Lilly and Company
- Location
- Phoenix, AZ + 35 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Gilead Sciences
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
Neuraptive Therapeutics Inc.
- Location
- Orlando, FL + 22 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Bristol-Myers Squibb
- Location
- Long Beach, CA + 23 other US sites
- Eligibility basics
- Ages 60–85
- RecruitingPhase 2
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Sparrow Pharmaceuticals
- Location
- Chandler, AZ + 60 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
Fin-Ceramica Faenza Spa
- Location
- Steamboat Springs, CO + 7 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 2
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Appello Pharmaceuticals, Inc.
- Location
- Little Rock, AR + 29 other US sites
- Eligibility basics
- Ages 30–80
- RecruitingPhase 2
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Anagram Therapeutics, Inc.
- Location
- Long Beach, CA + 19 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Boston Scientific Corporation
- Location
- Huntsville, AL + 39 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Kardigan, Inc.
- Location
- Birmingham, AL + 26 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CAR-T Long Term Follow Up (LTFU) Study
Novartis Pharmaceuticals
- Location
- Duarte, CA + 38 other US sites
- Eligibility basics
- Ages 0 mo–100
- Recruiting
Early Feasibility Study - Edwards APTURE Transcatheter Shunt System
Edwards Lifesciences
- Location
- Columbus, OH + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Sumitomo Pharma America, Inc.
- Location
- Birmingham, AL + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
AstraZeneca
- Location
- Mobile, AL + 30 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ELEVATE-HFpEF Clinical Study
Medtronic Cardiac Rhythm and Heart Failure
- Location
- Phoenix, AZ + 25 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Neuron23 Inc.
- Location
- Sun City, AZ + 43 other US sites
- Eligibility basics
- Ages 40–80